Ipsen (France)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (France), France, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
1.9K
Total Open
Publications
947
Total
Citations
38K
Open Access
Percentage
49%
Total
Publications
1.9K
Total Open
Publications
947
Total
Citations
38K
Breakdown
Publisher Open
21%
Both
24%
Other Platform Open
5%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
227
Hybrid 56%
477
No Guarantees 17%
149
Other Platform Open
Domain 77%
423
Institution 28%
153
Other Internet 14%
76
Public 9%
47
Preprint 6%
31
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 420 |
Europe PMC | Domain | 187 |
Semantic Scholar | Public | 41 |
DOI | Other Internet | 32 |
University College London - UCL Discovery | Institution | 24 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 24 |
Research Square | Preprint | 16 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 11 |
Le Centre pour la Communication Scientifique Directe - HAL - memSIC | Other Internet | 11 |
Le Centre pour la Communication Scientifique Directe - HAL - Inserm | Institution | 10 |